![]()
Imported Disease Annotations - CTDTerm | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | autistic disorder | | EXP | | 11554173 | CTD Direct Evidence: marker/mechanism | CTD | PMID:20957522 | Cocaine-Related Disorders | | EXP | | 11554173 | CTD Direct Evidence: marker/mechanism | CTD | PMID:18438686 | COVID-19 | | EXP | | 11554173 | CTD Direct Evidence: marker/mechanism | CTD | PMID:33307546 | Crohn's disease | | EXP | | 11554173 | CTD Direct Evidence: marker/mechanism | CTD | PMID:21102463 | multiple sclerosis | | EXP | | 11554173 | CTD Direct Evidence: marker/mechanism | CTD | PMID:19525955 | Paranoid Disorders | | EXP | | 11554173 | CTD Direct Evidence: marker/mechanism | CTD | PMID:18438686 | primary biliary cholangitis | | EXP | | 11554173 | CTD Direct Evidence: marker/mechanism | CTD | PMID:22961000 | psoriasis | | EXP | | 11554173 | CTD Direct Evidence: marker/mechanism | CTD | PMID:20953190 | rheumatoid arthritis | | EXP | | 11554173 | CTD Direct Evidence: marker/mechanism | CTD | PMID:23143596, PMID:30224649 | T-cell acute lymphoblastic leukemia | | EXP | | 11554173 | CTD Direct Evidence: marker/mechanism | CTD | PMID:23471820 | type 1 diabetes mellitus | | EXP | | 11554173 | CTD Direct Evidence: marker/mechanism | CTD | PMID:30224649 | |